Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Vor Biopharma Inc. - Common Stock (NQ:VOR)

18.05 +1.95 (+12.14%)

Streaming Delayed Price Updated: 2:53 PM EDT, Jun 29, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,082,784
Open	16.12
Bid (Size)	18.06 (700)
Ask (Size)	18.10 (100)
Prev. Close	16.10
Today's Range	15.85 - 19.11
52wk Range	6.500 - 65.80
Shares Outstanding	66,956,800
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China

June 08, 2026

From Vor Biopharma

Via GlobeNewswire

Telitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in China

June 08, 2026

From Vor Biopharma

Via GlobeNewswire

Performance

YTD	+55.1%	+55.1%
1 Month	+20.6%	+20.6%
3 Month	+22.8%	+22.8%
6 Month	+31.6%	+31.6%
1 Year	-44.3%	-44.3%

More News

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 01, 2026

From Vor Biopharma

Via GlobeNewswire

Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge ↗

May 30, 2026

Via The Motley Fool

VOR Shares Rally Over 40%In Pre-Market Trade After JPMorgan Initiates Bullish Coverage ↗

December 09, 2025

Via Stocktwits

Dyne Stock Is Up 56%. Here's What a $14 Million Stake Reduction Could Mean ↗

May 30, 2026

Via The Motley Fool

Vor Bio to Participate in the 2026 Jefferies Global Healthcare Conference

May 28, 2026

From Vor Biopharma

Via GlobeNewswire

Vor Bio Announces Publication of Interim Analysis of TELIGAN, a China Phase 3 Trial of Telitacicept in IgA Nephropathy, in The New England Journal of Medicine

May 14, 2026

From Vor Biopharma

Via GlobeNewswire

Vor Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update

May 13, 2026

From Vor Biopharma

Via GlobeNewswire

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

May 04, 2026

From Vor Biopharma

Via GlobeNewswire

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

April 01, 2026

From Vor Biopharma

Via GlobeNewswire

Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

March 30, 2026

From Vor Biopharma

Via GlobeNewswire

Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjögren’s Disease

March 30, 2026

From Vor Biopharma

Via GlobeNewswire

What's Behind The Jump In Vor Biopharma Stock? ↗

March 27, 2026

Via Benzinga

Vor Bio Announces $75 Million Private Placement with TCGX

March 27, 2026

From Vor Biopharma

Via GlobeNewswire

Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 23, 2026

From Vor Biopharma

Via GlobeNewswire

Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference

February 23, 2026

From Vor Biopharma

Via GlobeNewswire

Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference

January 06, 2026

From Vor Biopharma

Via GlobeNewswire

Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors

December 23, 2025

From Vor Biopharma

Via GlobeNewswire

Vor Bio Announces $150 Million Private Placement

December 15, 2025

From Vor Biopharma

Via GlobeNewswire

What's going on in today's session ↗

December 09, 2025

Via Chartmill

What's going on in today's pre-market session ↗

December 09, 2025

Via Chartmill

Futures Tread Cautiously Pre-Market As Investors Await Key Fed Decision: NVDA, XCUR, GME, CASY Among Stocks To Watch ↗

December 09, 2025

Via Stocktwits

Vor Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update

November 13, 2025

From Vor Biopharma

Via GlobeNewswire

Top movers analysis one hour before the close of the markets on 2025-11-11: top gainers and losers in today's session. ↗

November 11, 2025

Via Chartmill

Frequently Asked Questions

Is Vor Biopharma Inc. - Common Stock publicly traded?

Yes, Vor Biopharma Inc. - Common Stock is publicly traded.

What exchange does Vor Biopharma Inc. - Common Stock trade on?

Vor Biopharma Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Vor Biopharma Inc. - Common Stock?

The ticker symbol for Vor Biopharma Inc. - Common Stock is VOR on the Nasdaq Stock Market

What is the current price of Vor Biopharma Inc. - Common Stock?

The current price of Vor Biopharma Inc. - Common Stock is 18.05

When was Vor Biopharma Inc. - Common Stock last traded?

The last trade of Vor Biopharma Inc. - Common Stock was at 06/29/26 02:53 PM ET

What is the market capitalization of Vor Biopharma Inc. - Common Stock?

The market capitalization of Vor Biopharma Inc. - Common Stock is 1.21B

How many shares of Vor Biopharma Inc. - Common Stock are outstanding?

Vor Biopharma Inc. - Common Stock has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.